Find the Right Market Report

Search thousands of industry reports, market insights, and research studies in one place.

Not sure where to start? Try one of these:
Explore healthcare market intelligence and industry insights
Towards Healthcare

Antiviral and Antimicrobial Technology Manufacturers and Market Growth

Date : 22 May 2026

Latest Updates of Companies in the Antiviral and Antimicrobial Technology Market

Antiviral and Antimicrobial Technology Market Companies are Gilead Sciences, Pfizer, Merck & Co., GSK, Shionogi

Company Headquarters Latest Update
Gilead Sciences United States A leader in antiviral management, specifically known for Remdesivir.
Pfizer United States Pfizer produces a broad range of antibiotics like Zithromax and Zosyn for hospital and outpatient use.
Merck & Co. United States Recent advancement of life sciences with EnvisionTEC 3D Bioplotter. Achieve precision bioprinting for tissue engineering and medical care labs.
GSK United Kingdom This organization is known as Augmentin and is heavily involved in infectious disease management.
Shionogi Japan Specializes in new treatments, involving Gram-negative therapies such as Cefiderocol.

Recent Developments in Antiviral and Antimicrobial Technology Market

  • In November 2025, Biobond launched its sustainable three-layer antimicrobial coating in Mexico, partnering with Insumos Maez. Designed for commercial, residential, and industrial facilities, the launch aligns with President Claudia Sheinbaum’s nationwide infrastructure boom, protecting new buildings, hospitals, and transit hubs ahead of upcoming global events.
  • In July 2025, Researchers at the National Graphene Institute, in partnership with Smith & Nephew, developed a light-activated graphene oxide coating that offers sustained antimicrobial protection via silver ions. Published in Small, this technology aims to enhance hygiene across healthcare and industrial applications.

Market Growth

The global antiviral and antimicrobial technology market size was estimated at USD 16.84 billion in 2025 and is predicted to increase from USD 18.85 billion in 2026 to approximately USD 51.93 billion by 2035, expanding at a CAGR of 11.92% from 2026 to 2035.

Antiviral and Antimicrobial Technology Market Size is USD 18.85 Billion in 2026.

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.

Talk to an Analyst Contact Sales